Neurenati Therapeutics

About:

Neurenati Therapeutics is a biotechnology company that develops therapeutics for gastrointestinal rare diseases.

Website: https://www.neurenati.com

Twitter/X: neurenati

Top Investors: Investissement Quebec, Genson Capital

Description:

Neurenati Therapeutics operates as a biotechnology company developing an innovative treatment for Hirschsprung disease. Neurenati Therapeutics is pioneering a groundbreaking approach to address Hirschsprung disease (HSCR), a severe gastrointestinal (GI) birth defect marked by the absence of nerves in segments of the lower GI tract. Their cutting-edge technology introduces a novel therapy utilizing growth factors to effectively treat infants with HSCR, potentially eliminating the necessity for surgery and mitigating related risks and complications.